Katharine Batt, MD
Scientific Advisor, PHE
Formerly Assistant Professor, Hematology & Oncology, Wake Forest University School of Medicine
Until recently, Dr. Batt maintained an active clinical hematology practice at Wake Forest University. From 2015-2017, she was appointed Director of the Hemophilia Treatment Center; she also holds a joint appointment in the public health sciences department and a cross-appointment with the pediatrics’ department. She also consults with the London School of Economics on health policy projects, providing insight into the practice of clinical medicine in the United States. Her research interests include global disparities in physician salaries, care delivery strategies to vulnerable patient populations, and barriers to clinical care. Dr. Batt received a BA from Yale University, an MSc in International Health Policy from the London School of Economics and Political Science, and an MD from SUNY Buffalo. Her board certifications include internal medicine (ABIM, 2009) and palliative medicine (ABIM, 2010).
MD, University of State University of New York, Buffalo
MSc, London School of Economics & Political Science
BA, Yale University
ASSOCIATED CASE STUDIES
- Batt K, et al. Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) study. Patient Prefer Adherence. 2017.
- MacEwan JP, et al. Economic burden of multiple myeloma among patients in successive lines of therapy in the United States. Leuk Lymphoma. 2017.
- Thornton Snider J, et al. The option value of innovative treatments for non-small cell lung cancer and renal cell carcinoma. Am J Manag Care. 2017.